Table 5 Average and (1SD) variation based on six absorbed dose meausurements and combined point dose uncertainty for twenty dosimeters with NewTom 5G (12 × 8 cm FOV)
Dosimeter location | Dosimeter | Measured | Dose | Point dose |
|---|---|---|---|---|
in phantom | no. | dose (mGy) | uncertainty (%) | uncertainty (%) |
Tibia | 1 | 0.25 | 33% | 36 % |
Peroneus brevis | 2 | 0.33 | 27% | 31 % |
Gastrocnemius | 3 | 0.52 | 20% | 25 % |
Tibia | 4 | 0.48 | 22% | 26 % |
Tibialis anterior | 5 | 0.53 | 20% | 25 % |
Fibula | 6 | 0.73 | 17% | 22 % |
Tibia | 7 | 0.81 | 16% | 22 % |
Superior extensor Retinaculum | 8 | 3.86 | 7% | 16 % |
Tibia | 9 | 4.04 | 7% | 16 % |
Calcaneal tendon | 10 | 7.11 | 5% | 16 % |
Fibula | 11 | 6.53 | 5% | 16 % |
Lymp.vein | 12 | 10.4 | 4% | 16 % |
Posterior calcaneal tuberosity | 13 | 7.71 | 5% | 16 % |
Navicular | 14 | 4.09 | 7% | 16 % |
Talus | 15 | 4.66 | 6% | 16 % |
Metatarsals | 16 | 4.25 | 6% | 16 % |
Lymp.vein | 17 | 6.15 | 5% | 16 % |
Calcaneus | 18 | 6.45 | 5% | 16 % |
Calcaneal tuberosity | 19 | 7.33 | 5% | 16 % |
Flexor digitorum brevis | 20 | 3.40 | 7% | 17 % |